Product Dossier

CENRIFKI

Product Dossier for CENRIFKI (tolebrutinib, Sanofi-Aventis). ARTG record, PBS listing, PBAC outcomes, AusPAR — compiled by arcimedes.

• Sponsor: Sanofi-Aventis
• Active ingredient: tolebrutinib
• Therapeutic area: Neurology
• Same area: LACOMED
• Same area: LACOSAM

AusPAR (TGA)